SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (6630)5/11/1999 9:50:00 AM
From: Hank  Read Replies (2) of 7041
 
Just the type of response I would expect from you. I suppose a "letter of non-approval" doesn't meet your definition of rejection? The FDA will often reject drugs with the stipulation that they will reconsider if additional data is provided. However, these refilings fail more often than not. A truly safe and efficacious drug will always be approved the first time around. As far as I know, the word rejection does not bear a time limit on it. A rejection is a rejection, plain and simple. But I'm sure you'll come up with some way to twist the story in your favor when the reapplication gets rejected too. After all, that is what you get paid for isn't it?

You're pathetic. You can't even admit defeat after both of your legs and arms have been chopped off like that Knight in the movie "The Search for the Holy Grail".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext